
The Best Solution to Nonadherence
More than 50% of patients with schizophrenia are estimated to be nonadherent with their antipsychotic medication regimen. What treatment solutions are available?
One of the biggest challenges in treating schizophrenia is patient nonadherence to prescribed medications. Estimates suggest more than 50% of patients are partially or fully nonadherent with their antipsychotic medication regimens.
Long acting injections (LAI) may be the solution to this problem. Janssen Pharmaceutical Companies of Johnson & Johnson recently
To read more about this, see
Dr Gopal is the Head of Development Psychiatry at Janssen R&D (Johnson & Johnson). Follow him on Twitter:
Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.